OptimizeRx (OPRX) Shares Outstanding (Weighted Average) (2010 - 2026)

OptimizeRx's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $18.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1.57% year-over-year to $18.8 million; the TTM figure through Mar 2026 stood at $18.8 million (up 1.57% YoY), while the FY2025 annual figure was $18.6 million, up 1.43% from the prior year.
• Shares Outstanding (Weighted Average) came in at $18.8 million for Q1 2026 at OptimizeRx, up from $18.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $18.8 million in Q1 2026 to a low of $16.9 million in Q3 2023.
• A 5-year average of $18.0 million and a median of $18.2 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) grew 11.03% in 2022 and dropped 6.04% in 2023, its largest moves.
• OptimizeRx's Shares Outstanding (Weighted Average) stood at $17.8 million in 2022, then retreated by 3.71% to $17.1 million in 2023, then increased by 6.82% to $18.3 million in 2024, then grew by 1.43% to $18.6 million in 2025, then advanced by 1.11% to $18.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $18.8 million, $18.6 million, and $18.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison